UNSPSC 51273918: Cetylpyridinium/menthol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class NT300. This VA Drug Class (NT300) classifies this compound as belonging to the group ANESTHETICS, MUCOSAL.

UNSPSC 51273918 Cetylpyridinium/menthol is a Commodity code that in recent state and local procurement shows limited direct activity under its nominal scope. The three recent opportunities posted under this code diverge significantly from the specific antimicrobial active ingredients the code names: Seminole County, Florida solicited naloxone and drug deactivation systems; the Texas Health and Human Services Commission issued a Request for Information on direct-to-manufacturer prescription fulfillment; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration's Office of State Procurement issued an RFP for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. The issuing bodies span county health departments, state agencies, and cooperative purchasing platforms serving multi-jurisdictional participation. None of these solicitations targets cetylpyridinium or menthol products specifically, suggesting the code may be tagged inconsistently by procurement offices or the underlying commodity class captures a broader pharmaceutical purchasing category than the active-ingredient name implies.

Recent activity clusters in Florida, Texas, and Minnesota, with MMCAP's multi-state cooperative vehicle extending reach to Oregon and other participating jurisdictions. The Seminole County IFB (IFB60459723LAS, due July 26, 2023) sought annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries; the Texas HHS RFI (HHS0017013, due April 3, 2026) explored vendor capacity for direct-to-manufacturer prescription programs; and the MMCAP RFP (S1070000015802, due March 26, 2026) established multiple-award contracts for generic pharmaceuticals and OTC products through authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC. The misalignment between the code's nominal scope and actual procurement activity suggests that firms pursuing this code should verify issuing-body tagging with pre-bid inquiry before committing resources, as the mismatch indicates procurement-office classification variance rather than robust demand for cetylpyridinium/menthol products specifically.